In-vitro Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy.

Nima Hamzian, Maryam Hashemi, Mahdi Ghorbani, Seyed Amir Aledavood, Mohammad Ramezani, Mohammad Hossein Bahreyni Toosi
{"title":"<i>In-vitro</i> Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy.","authors":"Nima Hamzian,&nbsp;Maryam Hashemi,&nbsp;Mahdi Ghorbani,&nbsp;Seyed Amir Aledavood,&nbsp;Mohammad Ramezani,&nbsp;Mohammad Hossein Bahreyni Toosi","doi":"10.22037/ijpr.2019.14050.12131","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to modify the biological response of cells to ionizing radiation by combination therapy using radio-sensitizer agent and anticancer drug. Super paramagnetic iron oxide nanoparticles (SPIONs) were prepared and used with gemcitabine (Gem). These two agents were encapsulated simultaneously intopoly (D, L-lactic-co-glycolic acid) (PLGA) to form multifunctional drug delivery system. The physicochemical characteristics of the nanoparticles (NPs) were studied. The dose enhancement ratio (DER) of various treatment groups was calculated and compared using human breast cancer cell line (MCF-7). The DER for PLGA-SPION-Gem was the highest at 1 Gy<sup>60</sup>Co (3.18). Cumulative effect from simultaneous use of two radiosensitizer (Gem and SPIONs) was observed. Thus, we have successfully developed PLGA NPs loaded with gemcitabine and SPIONas a radiosensitizersystem which potentially could be used in radiotherapy.</p>","PeriodicalId":416671,"journal":{"name":"Iranian Journal of Pharmaceutical Research : IJPR","volume":" ","pages":"1694-1703"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059059/pdf/","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Research : IJPR","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.22037/ijpr.2019.14050.12131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

This study aimed to modify the biological response of cells to ionizing radiation by combination therapy using radio-sensitizer agent and anticancer drug. Super paramagnetic iron oxide nanoparticles (SPIONs) were prepared and used with gemcitabine (Gem). These two agents were encapsulated simultaneously intopoly (D, L-lactic-co-glycolic acid) (PLGA) to form multifunctional drug delivery system. The physicochemical characteristics of the nanoparticles (NPs) were studied. The dose enhancement ratio (DER) of various treatment groups was calculated and compared using human breast cancer cell line (MCF-7). The DER for PLGA-SPION-Gem was the highest at 1 Gy60Co (3.18). Cumulative effect from simultaneous use of two radiosensitizer (Gem and SPIONs) was observed. Thus, we have successfully developed PLGA NPs loaded with gemcitabine and SPIONas a radiosensitizersystem which potentially could be used in radiotherapy.

Abstract Image

Abstract Image

Abstract Image

负载吉西他滨的多功能PLGA-SPION纳米粒子作为放射增敏剂用于放射治疗的体外研究。
本研究旨在通过放射增敏剂和抗癌药物的联合治疗来改变细胞对电离辐射的生物反应。制备了超顺磁性氧化铁纳米颗粒(SPIONs),并与吉西他滨(Gem)配合使用。将这两种药物同时包封在topoly (D, l -乳酸-羟基乙酸)(PLGA)中,形成多功能给药体系。研究了纳米颗粒的物理化学特性。以人乳腺癌细胞系MCF-7为研究对象,计算并比较各治疗组的剂量增强比(DER)。plga - spon - gem的DER最高,为1 Gy60Co(3.18)。观察了同时使用两种放射增敏剂(Gem和SPIONs)的累积效应。因此,我们成功地开发了装载吉西他滨和spiona的PLGA NPs,作为一种潜在的放射增敏剂系统,可用于放射治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书